Topical dermatological preparations, particularly locally acting generic products, face challenges in bioequivalence(BE) assessment due to the inapplicability of pharmacokinetic(PK)-based endpoints and the high cost and complexity of clinical endpoint studies. This problem has prompted regulatory agencies to develop alternative in vitro and in vivo methods based on non-clinical endpoints for BE evaluation. Among these approaches, the characterization of physicochemical and structural properties(Q3) serves as an in vitro testing method that predicts and compares product quality and drug performance by assessing the physicochemical and structural attributes of formulations, thereby providing scientific supports for in vitro BE demonstration of topical preparations. This article systematically reviews the progress in Q3 characterization of topical dermatological preparations based on guidance documents issued by regulatory agencies and relevant literature worldwide.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |